Eventide Healthcare & Life Sciences Fd Cl I OverviewEventide Healthcare & Life Sciences Fd Cl I's EBIT is $0, below the sector sector average of $2.6T.
Get informed when a big investor buys or sells
+ FollowAs of May 31, 2023
Trailing 12 months ending May 31, 2023
As of the most recent data (May 2023), ETIHX shows a EBIT of $0. In the prior-year period, the figure was $0. That is below the sector sector average of $2.6T. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, ETIHX's EBIT is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Eventide Healthcare & Life Sciences Fd Cl I is outperforming or lagging.
The its sector sector average EBIT is about $2.6T. Eventide Healthcare & Life Sciences Fd Cl I is at $0, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how ETIHX stacks up against individual peers as well.
Tracking ETIHX's ebit over time shows whether Eventide Healthcare & Life Sciences Fd Cl I is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this ebit page, Stockcircle has Eventide Healthcare & Life Sciences Fd Cl I's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $0) with ownership activity and broader fundamentals.
